Emmanuelle Boishardy – General Manager, GSK Czech Republic
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
Omega Pharma is a dynamic organization specialized in developing, manufacturing and sale of medical devices, food supplements and medical cosmetics as on the OTC pharmaceutical market as in wide distribution on the mass-market. It is part of the multinational group Omega Pharma which is headquartered in Belgium and present in 40 countries.
High specialization, professionalism and superior customer service have enabled a dynamic development of the company and it has been included among the major players on the market.
From the very beginning, Omega Pharma has been a marketing-driven company with a strong focus on customer’s needs, requirements and resulting satisfaction. It holds many patents and applies unique solutions to high-efficiency products in product lines.
The company now has its own Development Center of Excellence. In terms of research and its application we interact with renowned centers in the Czech Republic and across Europe.
The products registered at the Industrial Property Rights in Czech Republic come from our own research laboratory. We participate in research and development of the products with guaranteed support of the state organizations and our priorities include not only development but also responsible clinical testing of each product prior to launching it into the market.
Contact
OMEGA PHARMA A.S.
Drážní 253/7
Brno 62700
+420 800 400 113
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the company’s success in the Central Eastern European region. Corina…
Josef Kredba, country manager Czech Republic at G.L. Pharma, an Austrian pharmaceutical company, explains how the company has returned to growth in the challenging Czech generics market and shares his…
Jan Škrha, president of the Czech Diabetes Society (ČDS), provides insight into the most crucial advances in the quality care of Diabetes, which relies on the indispensable cooperation between specialists…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market in the Czech Republic, gives an overview of the current…
Tomáš Dolezal, president of the International Society for Pharmacoeconomics and Outcomes (ISPOR) Czech Regional Chapter and director of the Institute of Health Economics and Technology Assessment (iHETA), gives an overview…
Sandoz’s Jiří Hanzlík, country head for the Czech Republic, evaluates the Czech affiliate’s role in contributing to the success of Sandoz globally as well as its position in the country.…
Jakub Dvořáček, CEO of the Czech Association of Innovative Pharmaceutical Industry (AIFP), describes the thorough review of the reimbursement scheme the association has worked on alongside other key stakeholders in…
Bioinova’s CEO and managing director MUDr Peter Bauer PhD introduces the biotech company’s shift from a university spin-off to a privately held entity. Whilst describing the powerful properties of stem…
Štěpán Svačina, Chairman of the Czech Medical Association (CzMA), gives insights into the challenges that the Czech Republic faces in bringing change to the life sciences infrastructure. Whilst pointing out…
The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech…
See our Cookie Privacy Policy Here
